Compounds > cefodizime
Page last updated: 2024-08-23

cefodizime and Pneumonia, Bacterial

cefodizime has been researched along with Pneumonia, Bacterial in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bian, R; Gao, P; Sun, S; Wang, B; Wei, C1
Dagrosa, EE; Facco, EB; Mendoza, F; Palombini, BC; Piovano, CF1

Trials

2 trial(s) available for cefodizime and Pneumonia, Bacterial

ArticleYear
[Cefodizime increases peripheral blood CD4/CD8 and Th1/Th2 ratios in senile patients with bacterial pneumonia].
    Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology, 2015, Volume: 31, Issue:4

    Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Blood Cell Count; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cefotaxime; Female; Flow Cytometry; Humans; Interferon-gamma; Interleukin-10; Interleukin-2; Interleukin-4; Male; Middle Aged; Pneumonia, Bacterial; Th1 Cells; Th2 Cells

2015
Cefodizime once daily in the treatment of lower respiratory tract infections.
    Arzneimittel-Forschung, 1997, Volume: 47, Issue:5

    Topics: Adult; Aged; Bronchitis; Cefotaxime; Cephalosporins; Female; Humans; Male; Middle Aged; Pneumonia, Bacterial; Respiratory Tract Infections

1997